To investigate the relationship between menopausal hormone therapy (MHT) and sex steroid concentrations and metabolism in adipose tissue among postmenopausal women, highlighting its clinical significance.
Key Findings:
Women on MHT had significantly higher estrogen concentrations and estrogen-to-androgen ratios in both subcutaneous and visceral adipose tissue compared to nonusers, suggesting potential clinical implications for managing postmenopausal health.
In visceral adipose tissue, higher estradiol doses correlated with increased estrogen-to-androgen ratios among MHT users.
Testosterone concentrations were lower in visceral adipose tissue of MHT users compared to nonusers.
Interpretation:
The differences in sex steroid concentrations in adipose tissue between MHT users and nonusers may indicate altered local metabolism of sex steroids due to MHT, potentially influenced by [insert potential mechanisms].
Limitations:
Small sample size and limited adipose tissue specimens, which may affect the generalizability of the findings.
Findings require cautious interpretation and further gene expression analyses.
Conclusion:
Further longitudinal studies are needed to explore the impact of MHT on body composition, cardiometabolic health, and local steroid metabolism in postmenopausal women, particularly focusing on [insert specific areas for future research].
A large Epic Cosmos analysis linked vaginal estrogen prescribing with lower rates of sepsis, hospital admission, and death following recurrent urinary tract infection, but researchers cautioned that prescribing may also mark broader differences in care.
